[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@Dyne_tx](/creator/twitter/Dyne_tx)
"Sarahs family lives with #DM1 across generations. On #MytonicDystrophy Awareness Day we share her story and journey with DM1. Watch the full video:"  
[X Link](https://x.com/Dyne_tx/status/1967588279236034564) [@Dyne_tx](/creator/x/Dyne_tx) 2025-09-15T13:56Z 1250 followers, XXX engagements


"Today we mark the 5th Annual International #MyotonicDystrophy Awareness Day. At Dyne were honored to be a member of the Global Alliance for Myotonic Dystrophy to help raise awareness and advance research. Learn more:"  
[X Link](https://x.com/Dyne_tx/status/1967642343609082121) [@Dyne_tx](/creator/x/Dyne_tx) 2025-09-15T17:31Z 1250 followers, XXX engagements


"DYNE-251 has been granted Orphan Drug designation in Japan for the treatment of patients with #Duchenne muscular dystrophy (#DMD) who have mutations in the DMD gene that are amenable to exon XX skipping. Read here:"  
[X Link](https://x.com/Dyne_tx/status/1972644303873712392) [@Dyne_tx](/creator/x/Dyne_tx) 2025-09-29T12:47Z 1250 followers, XXX engagements


"Were pleased to share new positive data from our Phase 1/2 DELIVER trial of DYNE-251 in DMD at the @MDAorg Conference. Learn more: $DYN"  
[X Link](https://x.com/Dyne_tx/status/1901600682899353668) [@Dyne_tx](/creator/x/Dyne_tx) 2025-03-17T11:45Z 1250 followers, XXX engagements


"Today we shared our Q2 2025 results highlighting progress for our #DMD and #DM1 programs. Read here: $DYN"  
[X Link](https://x.com/Dyne_tx/status/1949927871377449004) [@Dyne_tx](/creator/x/Dyne_tx) 2025-07-28T20:20Z 1250 followers, XXX engagements


"Today we announced that the @US_FDA has granted Breakthrough Therapy Designation to DYNE-251 for the treatment of patients with DMD amenable to exon XX skipping. Read here:"  
[X Link](https://x.com/Dyne_tx/status/1952348821700120651) [@Dyne_tx](/creator/x/Dyne_tx) 2025-08-04T12:40Z 1250 followers, XXX engagements


"Data from the ongoing Phase 1/2 ACHIEVE trial in DM1 to be presented at the Congress of the @WorldMuscleSoc continue to demonstrate a favorable safety and efficacy profile for zeleciment basivarsen (formerly known as DYNE-101). See the data:"  
[X Link](https://x.com/Dyne_tx/status/1975321446650991006) [@Dyne_tx](/creator/x/Dyne_tx) 2025-10-06T22:05Z 1250 followers, XXX engagements


"Kathleen Tregoning joined us for our FORCEs in Biotech series sharing insights on government affairs: Government affairs isnt bowlingits billiards. Every move every conversation every engagement bounces off another. Its all connected"  
[X Link](https://x.com/Dyne_tx/status/1978484034243039739) [@Dyne_tx](/creator/x/Dyne_tx) 2025-10-15T15:32Z 1249 followers, XXX engagements